Sign In
Buy NVO
$47.64
+0.230 (+0.485%)
At Close: Jun 25, 2026
Novo Nordisk announces changes in Executive Management
02:00am, Thursday, 03'rd Apr 2025
Bagsværd, Denmark, 3 April 2025 – Novo Nordisk today announced the following changes in Executive Management. After a distinguished career of 28 years with Novo Nordisk, hereof seven years as execu
Coffers swelling on Wegovy sales, Novo Holdings doubles income and returns in 2024
01:32am, Wednesday, 02'nd Apr 2025
Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk , nearly doubled annual income and investment returns to a record 8 billion euros ($8.66 billion) in 2024, it said on Wedne
Bernstein's Courtney Breen: Merck, Novo Nordisk, others at high risk from tariffs
12:11pm, Tuesday, 01'st Apr 2025
Courtney Breen, Bernstein senior analyst, joins CNBC's 'Money Movers' to discuss how to draw the line between tariff risks and company financials in pharmaceuticals, which companies are most at risk,
Biotech Stocks Q1 2025 Recap: Winners And Underperformers
02:34pm, Monday, 31'st Mar 2025
Investing in biotech can be highly rewarding but is fraught with risks; understanding past catalysts can help investors make informed decisions and minimize downside risk. CervoMed Inc. surged over 30
Novo Nordisk: Finally A Buying Opportunity
10:37am, Sunday, 30'th Mar 2025
Novo Nordisk has experienced a 50% drop due to potential tariffs and recent clinical trial results but remains strong in diabetes treatment, insulin, and GLP-1 products. I outline the bull case for NV
Eli Lilly Vs. Novo Nordisk: Which Is The Better Bargain For Investors
05:00am, Sunday, 30'th Mar 2025
Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets, valued at more than $100 billion. Each of them has advantages, as well as dark spots in the pipeline of drugs a
Bagsværd, Denmark, 29 March 2025 – Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that Rybelsus® (oral semaglutide) significantly reduced
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
02:30pm, Saturday, 29'th Mar 2025
Novo Nordisk said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial. The pill lowered the risk of cardiovascular-related death, heart attack and stroke by 14% compared to
GLP-1 space will remain two player over the medium to long term, says Mizuho's Jared Holz
06:21pm, Friday, 28'th Mar 2025
Jared Holz, Mizuho, joins 'Closing Bell Overtime' to talk Novo Nordisk sinking on lighter-than-expected GLP-1 demand.
1 no-brainer biotech giant to buy in April
12:51pm, Friday, 28'th Mar 2025
The advent of weight-loss drugs, primarily semaglutide, proved to be an immense boon for biotech giants — primarily Novo Nordisk and Eli Lilly.
Investors Heavily Search Novo Nordisk A/S (NVO): Here is What You Need to Know
10:01am, Friday, 28'th Mar 2025
Recently, Zacks.com users have been paying close attention to Novo Nordisk (NVO). This makes it worthwhile to examine what the stock has in store.
Novo Nordisk says compounded drugs are hurting Wegovy sales
09:41am, Friday, 28'th Mar 2025
CNBC's Karen Gilchrist discusses the impact of U.S. compounded weight loss drugs and potential tariffs on obesity drug giant Novo Nordisk.
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'
09:37am, Friday, 28'th Mar 2025
Novo Nordisk has defended disappointing trial results for its much-hyped next generation obesity drug candidate CagriSema, insisting it will be an "important" weight loss treatment. "I'm very confiden
Change In Australian Shareholder Registry Services
09:11am, Friday, 28'th Mar 2025
PERTH, Australia, March 28, 2025 (GLOBE NEWSWIRE) -- Novo Resources Corp. (Novo or the Company) (ASX: NVO) (TSX: NVO) (OTCQX: NSRPF) advises that as of Monday, 31 March 2025, Novo has changed its prov
Penny Stock Lexicon Pharmaceuticals Surges On Obesity Pact Worth $1 Billion With Novo Nordisk
09:02am, Friday, 28'th Mar 2025
Lexicon Pharmaceuticals Inc. LXRX stock is trading higher on Friday.
